Clinical Drug Development Data Analysis: Concepts

PMC 6212 4 Quarter Hours
Course Level CPS - Graduate
Description Examines the process of planning, collecting, analyzing, and reporting data from drug development studies. Focuses on the goals of each phase (1–4) of the clinical drug development process and how to achieve these objectives within the confines of the FDA regulations and ICH guidelines. Covers requirements in other countries, including the UK Data Protection Act, issues related to the differences between the development of drugs for oncologic or AIDS indications compared to traditional drugs, cultural influences, current standards of therapy, the need for validated tools, and failure analyses. Prereq. (a) PJM 6000 or (b) BTC 6210, RGA 6100, and either RGA 6201 or RGA 6202.

Prerequisites

Students should refer to the Registrar’s Course Catalog for course prerequisite information.

 

Course Sections

Section 01
CRN 20839
Session Winter 2017 CPS Quarter - Full Term
Class Meeting Dates 01/09/2017 to 04/01/2017
Instructor Angela Knox
Campus Boston Main Campus
Course Format Traditional
Costs Course Cost: View Tuition Rates | Books: Visit NU Bookstore Site
Section 05
CRN 20212
Session Winter 2017 CPS Quarter - Full Term
Class Meeting Dates 01/09/2017 to 04/01/2017
Campus Online Campus
Course Format Online
Costs Course Cost: View Tuition Rates | Books: Visit NU Bookstore Site
Next Term Starts
  • Winter Graduate
    Jan 9, 2017 (6- and 12-week classes)
    Feb 20, 2017 (6-week classes)

Academic Calendar

Talk to an Enrollment Coach

We can walk you through your program options and the application process.

 

Call Toll Free:
877.668.7727
Email:
Contact Us
©